文献速递心律失常冠心病心力衰竭与心肌病

心肌梗死后早期左室功能不全中室性心律失常的预后价值:法国全国WICD-MI研究

Prognostic value of ventricular arrhythmia in early post-infarction left ventricular dysfunction: the French nationwide WICD-MI study.
PubMed 文献 · Eur Heart J · 2024-01-01

本研究基于法国全国注册的1032例急性心肌梗死后LVEF≤35%、出院时佩戴可穿戴除颤器3个月后植入ICD的患者,回顾分析心肌梗死后早期(出院3个月内)发生持续性室性心律失常对预后的预测价值。结果显示,佩戴WCD期间发生持续性VA者1年复发持续性VA风险(校正HR 6.91,95%CI 3.73-12.81,P<.0001)及1年死亡率(校正HR 2.86,95%CI 1.28-6.39,P=.012)显著升高。

要点

  • 心肌梗死后早期LVEF≤35%患者中,WCD期间发生持续性VA者1年VA复发风险显著升高。
  • 该早期VA事件独立预测1年死亡率升高,提示需加强此类患者监测与随访。
  • 结果支持在心肌梗死后早期对高危患者进行心律失常风险评估。

核心结论

  • 在LVEF≤35%患者中,心肌梗死后早期发生的持续性室性心律失常可预测持续性VA复发及1年死亡。

研究设计与样本

  • 回顾性研究,基于法国全国注册的1032例急性心肌梗死后LVEF≤35%患者,出院时处方WCD 3个月后植入ICD。
  • 按是否在WCD期间发生持续性VA分为VA+/WCD组(n=72)与VA-/WCD组(n=960),中位随访30.9个月。

主要发现

  • ICD植入后1年内持续性VA发生率在VA+/WCD组为22.2%、VA-/WCD组为3.5%(P<.0001)。
  • WCD期间持续性VA独立预测1年持续性VA复发(校正HR 6.91;95%CI 3.73-12.81;P<.0001)。
  • WCD期间持续性VA独立预测随访结束时持续性VA复发(校正HR 3.86;95%CI 2.37-6.30;P<.0001)。
  • WCD期间持续性VA独立预测1年死亡率(校正HR 2.86;95%CI 1.28-6.39;P=.012)。

临床怎么用

  • 对心肌梗死后早期LVEF≤35%且佩戴WCD期间发生持续性VA的患者,应视为VA复发与死亡高危人群,加强监测与随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Prophylactic implantable cardioverter-defibrillators (ICDs) are not recommended until left ventricular ejection fraction (LVEF) has been reassessed 40 to 90 days after an acute myocardial infarction. In the current therapeutic era, the prognosis of sustained ventricular arrhythmias (VAs) occurring during this early post-infarction phase (i.e. within 3 months of hospital discharge) has not yet been specifically evaluated in post-myocardial infarction patients with impaired LVEF. Such was the aim of this retrospective study. METHODS: Data analysis was based on a nationwide registry of 1032 consecutive patients with LVEF ≤ 35% after acute myocardial infarction who were implanted with an ICD after being prescribed a wearable cardioverter-defibrillator (WCD) for a period of 3 months upon discharge from hospital after the index infarction. RESULTS: ICDs were implanted either because a sustained VA occurred while on WCD (VA+/WCD, n = 72) or because LVEF remained ≤35% at the end of the early post-infarction phase (VA-/WCD, n = 960). The median follow-up was 30.9 months. Sustained VAs occurred within 1 year after ICD implantation in 22.2% and 3.5% of VA+/WCD and VA-/WCD patients, respectively (P < .0001). The adjusted multivariable analysis showed that sustained VAs while on WCD independently predicted recurrence of sustained VAs at 1 year (adjusted hazard ratio [HR] 6.91; 95% confidence interval [CI] 3.73-12.81; P < .0001) and at the end of follow-up (adjusted HR 3.86; 95% CI 2.37-6.30; P < .0001) as well as 1-year mortality (adjusted HR 2.86; 95% CI 1.28-6.39; P = .012). CONCLUSIONS: In patients with LVEF ≤ 35%, sustained VA during the early post-infarction phase is predictive of recurrent sustained VAs and 1-year mortality.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Echivard M, Sellal JM, Ziliox C, et al. Prognostic value of ventricular arrhythmia in early post-infarction left ventricular dysfunction: the French nationwide WICD-MI study. Eur Heart J. 2024. PMID: 39299922. doi:10.1093/eurheartj/ehae575

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。